|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | H01L 29/02 | (2006.01) |
| A61K 31/445 | (2013.01) | ||
| C07D 211/44 | (2013.01) | ||
| H01L 28/90 | (2013.01) | ||
| A61P 25/00 | (2018.01) |
| (11) | Patento numeris | 2831043 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13710951.8 |
| Europos patento paraiškos padavimo data | 2013-03-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-02-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2022-07-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/029612 |
| Data | 2013-03-07 |
| (87) | Numeris | WO 2013/148103 |
| Data | 2013-10-03 |
| (30) | Numeris | Data | Šalis |
| 201261616159 P | 2012-03-27 | US |
| (72) |
BOYD, Robert , US
RYBCZYNSKI, Philip, J. , US
SHETH, Kamlesh , US
|
| (73) |
Amicus Therapeutics, Inc. ,
3675 Market Street, Philadelphia, PA 19104,
US
|
| (54) | NOVEL COMPOUNDS FOR PREVENTING AND/OR TREATING LYSOSOMAL STORAGE DISORDERS AND/OR DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM |
| NOVEL COMPOUNDS FOR PREVENTING AND/OR TREATING LYSOSOMAL STORAGE DISORDERS AND/OR DEGENERATIVE DISORDERS OF THE CENTRAL NERVOUS SYSTEM |